BTZO-1
SIGMA/SML0121 - ≥98% (HPLC)
Synonym: 2-
CAS Number: 99420-15-2
Empirical Formula (Hill Notation): C13H8N2OS
Molecular Weight: 240.28
MDL Number: MFCD19690951
Linear Formula: C13H8N2OS
Product Type: Chemical
| assay | ≥98% (HPLC) |
| color | white to tan |
| form | powder |
| InChI | 1S/C13H8N2OS/c16-12-9-5-1 |
| InChI key | GBAKVEWPYUIGHN-UHFFFAOYSA |
| originator | Takeda |
| Quality Level | 100 ![]() |
| SMILES string | O=C1N=C(Sc2ccccc12)c3cccc |
| solubility | DMSO: ≥7 mg/mL |
| storage temp. | 2-8°C |
| Application: | BTZO-1 may be used in ARE-mediated gene expression studies. |
| Biochem/physiol Actions: | BTZO-1 is a suppressor of cardiomyocyte apoptosis presumably by activation of antioxidant response element (ARE)-mediated gene expression. BTZO-1 binds to the macrophage migration inhibitory factor (MIF) that is required to activate the glutathione S-transferase Ya subunit (GST Ya) gene ARE. |
| Biochem/physiol Actions: | suppressor of cardiomyocyte apoptosis; ligand of macrophage migration inhibitory factor (MIF) |
| Features and Benefits: | This compound was developed by Takeda . To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here . |
| Packaging: | 5, 25 mg in glass bottle |
| Hazard Codes | Xn |
| Risk Statements | 22 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | ≥98% (HPLC) |
| Storage Temp. | 2-8°C |
| UNSPSC | 12352200 |

